(Q33242531)

24 July 2017

title

Cancer immunomics: using autoantibody signatures in the early detection of prostate cancer (English)

1 reference

24 July 2017

1 reference

1 reference

Timothy J Bradford

1

1 reference

24 July 2017

Xiaoju Wang

series ordinal

2

1 reference

24 July 2017

Arul M Chinnaiyan

series ordinal

3

1 reference

24 July 2017

publication date

1 May 2006

1 reference

24 July 2017

1 reference

24 July 2017

volume

24

1 reference

24 July 2017

issue

3

1 reference

24 July 2017

page(s)

237-242

1 reference

Epidemiology of prostate cancer

24 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.033

PSA, PSA density, PSA density of transition zone, free/total PSA ratio, and PSA velocity for early detection of prostate cancer in men with serum PSA 2.5 to 4.0 ng/mL

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.033

Human neoplasms elicit multiple specific immune responses in the autologous host

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.033

Identification of multiple cancer/testis antigens by allogeneic antibody screening of a melanoma cell line library

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.033

A survey of the humoral immune response of cancer patients to a panel of human tumor antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.033

An immune response manifested by the common occurrence of annexins I and II autoantibodies and high circulating levels of IL-6 in lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.033

Identification of tumor-associated antigens by screening phage-displayed human cDNA libraries with sera from tumor patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.033

Antibodies to HSP70 and HSP90 in serum in non-small cell lung cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.033

Tumour-associated antigens in multiple myeloma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.033

New paths in human cancer serology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.033

Autoantibodies to prostasomes as new markers for prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.033

Fingerprinting the circulating repertoire of antibodies from cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.033

Humoral immune response to alpha-methylacyl-CoA racemase and prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.033

alpha-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.033

P504S: a new molecular marker for the detection of prostate carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.033

Autoantibody signatures in prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.033

10.1016/J.UROLONC.2005.11.033

7 January 2021

Identifiers

DOI

1 reference

24 July 2017

1 reference